XML 61 R50.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity - Warrants (Details) - USD ($)
3 Months Ended 12 Months Ended 15 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2025
Mar. 12, 2025
Mar. 11, 2025
May 15, 2023
Other disclosures            
Purchaseable stock 2,386,325 2,368,072 2,386,325 2,379,508 23,796,200  
Compensation expense $ 160,000          
Warrants            
Number of Other than Options            
Outstanding and exercisable, beginning balance (in shares) 263,957          
Outstanding, ending balance (in shares) 263,957 263,957 263,957      
Exercisable (in shares) 163,957   163,957      
Weighted Average Exercise Price            
Outstanding and exercisable, beginning balance (in dollars per share) $ 9.73          
Outstanding, ending balance (in dollars per share) 9.73 $ 9.73 $ 9.73      
Exercisable, ending balance (in dollars per share) $ 6.52   $ 6.52      
Weighted Average Remaining Contractual Life (in Years), Outstanding 8 years 8 months 15 days 8 years 11 months 15 days        
Weighted Average Contractual Life (in Years), Exercisable 9 years 25 days          
Aggregate Intrinsic Value, Outstanding $ 0 $ 0 $ 0      
Aggregate Intrinsic Value, Exercisable 0   0      
Other disclosures            
Compensation expense $ 0 $ 0        
Warrants | Halston License            
Other disclosures            
Warrant term           10 years
Purchaseable stock           100,000
Warrants outstanding, exercise price (in dollars per share)           $ 15
Contra-revenue related to warrants held by licensee     $ 10,000.00      
Number of shares vested 0